课题基金 / 基金详情

Brain Insulin Resistance and Development of Alzheimers Disease

Brain Insulin Resistance and Development of Alzheimers Disease
脑胰岛素抵抗与阿尔茨海默病的发展
批准号:
9904967
负责人:
MARK Andrew ESPELAND
金额:
$37.36万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-01 至 2021-03-31
关键词:
AKT1 geneAKT2 geneAKT3 geneAdministrative SupplementAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAlzheimer&aposs disease riskAlzheimer’s disease biomarkerAmyloid beta-ProteinAntibodiesBindingBiological MarkersBiological SciencesBiometryBloodBlood specimenBovine Serum AlbuminBrainBrain regionBuffersCalciumCase-Control StudiesCellsCentrifugationCerebral cortexClinical TrialsCognitionCognitiveComplexDataDementiaDevelopmentDiabetes MellitusElderlyEnergy IntakeExcisionExposure toGLUT-3 proteinGLUT4 geneGenomicsGlucoseGlycineGoalsGonadal Steroid HormonesHealthHippocampus (Brain)HourHumanIRS1 geneImpaired cognitionIn VitroIncubatedInflammationInsulinInsulin ReceptorInsulin ResistanceLinkMagnesiumMagnetic Resonance ImagingMaintenanceMeasuresMemoryMetabolicMethodsMolecularMusNeural Cell Adhesion Molecule L1NeuronsNon-Insulin-Dependent Diabetes MellitusObesityOverweightParticipantPathologyPathway interactionsPatientsPerformancePeripheralPhosphoric Monoester HydrolasesPhosphoserinePhysical activityPlant ResinsPlasmaPopulationPrecipitationProtease InhibitorProteinsPublishingRandomized Controlled Clinical TrialsResearch PersonnelResistance developmentRiskRoleSLC2A1 geneSalineSamplingSepharoseSignal PathwaySkeletal MuscleStreptavidinSurfaceSuspensionsSymptomsSystemTemperatureTestingThromboplastinTimeTissuesTranscriptTyrosineabeta accumulationadjudicateagedangiogenesisbrain pathwaycell typecerebral atrophycognitive developmentcognitive functioncognitive performancecohortcost effectivedesigneuglycemiaexosomeimprovedindexinginhibitor/antagonistinsulin sensitivityinsulin signalingintercellular communicationintravenous administrationlifestyle interventionmild cognitive impairmentmind body interactionmultidisciplinarynanoparticlephosphatase inhibitorpreservationrelating to nervous systemspecific biomarkerstargeted biomarkertau Proteinsweight loss intervention

项目摘要

项目成果

MARK Andrew ESPELAND的其他基金

相关文献

中文摘要
翻译
项目摘要R01 AG058571 2型糖尿病,以骨骼肌等周围组织的胰岛素抵抗为特征, 增加AD风险。然而,目前尚不清楚两者之间是否存在类似或更强的关系 脑内胰岛素抵抗与阿尔茨海默病。建议的行政副刊的目标是看 未来的想法,虽然在最初的范围内,是进一步解开分子通路连接 通过检测神经源性强化生活方式干预认知功能障碍的发展 脑胰岛素抵抗和阿尔茨海默病(AD)病理的血液外体生物标记物。
英文摘要
Project Summary R01 AG058571 Type 2 diabetes, characterized by insulin resistance in peripheral tissues such as skeletal muscle, increases AD risk. However, it is unclear whether there is a similar, or stronger, relationship between insulin resistance in the brain and AD. The goal of the proposed administrative supplement to Look AHEAD-MIND, while within the original scope, is to further unravel molecular pathways linking the intensive lifestyle intervention to the development of cognitive impairment by examining neural-derived blood exosome biomarkers for brain insulin resistance and Alzheimer's disease (AD) pathologies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Data Core
Data Core
LA-Aging Diversity Supplement
Data Core